Maria Efstathopoulou
Overview
Explore the profile of Maria Efstathopoulou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
82
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chatzikonstantinou T, Scarfo L, Minga E, Karakatsoulis G, Chamou D, Kotaskova J, et al.
Hemasphere
. 2024 Sep;
8(9):e70004.
PMID: 39290716
No abstract available.
2.
Sachanas S, Stefanaki C, Marinos L, Yiakoumis X, Moschogiannis M, Koulieris E, et al.
In Vivo
. 2024 Aug;
38(5):2540-2544.
PMID: 39187345
Background/aim: Hairy cell leukemia (HCL) is a well-known lymphoproliferative disease with very effective treatment approaches primarily relying on purine analogues. However, these treatments are associated with profound and prolonged immunosuppression....
3.
Chatzikonstantinou T, Scarfo L, Karakatsoulis G, Minga E, Chamou D, Iacoboni G, et al.
EClinicalMedicine
. 2023 Nov;
65:102307.
PMID: 38033506
Background: Patients with chronic lymphocytic leukemia (CLL) have a higher risk of developing other malignancies (OMs) compared to the general population. However, the impact of CLL-related risk factors and CLL-directed...
4.
Visentin A, Chatzikonstantinou T, Scarfo L, Kapetanakis A, Demosthenous C, Karakatsoulis G, et al.
Am J Hematol
. 2023 Sep;
98(12):1856-1868.
PMID: 37772428
In this retrospective international multicenter study, we describe the clinical characteristics and outcomes of patients with chronic lymphocytic leukemia (CLL) and related disorders (small lymphocytic lymphoma and high-count monoclonal B...
5.
Efstathopoulou M, Zoi K, Siakantaris M, Koumbi D, Zannou A, Triantafyllou E, et al.
Acta Haematol
. 2023 Aug;
146(6):531-539.
PMID: 37557081
Chronic myelogenous leukemia at blast crisis with a T-cell phenotype (T-ALL CML-BC) at diagnosis, without any prior history of CML is extremely rare. After the introduction of tyrosine kinase inhibitors...
6.
Antic D, Milic N, Chatzikonstantinou T, Scarfo L, Otasevic V, Rajovic N, et al.
J Hematol Oncol
. 2022 Aug;
15(1):116.
PMID: 36028857
Background: Patients with chronic lymphocytic leukemia (CLL) may be more susceptible to COVID-19 related poor outcomes, including thrombosis and death, due to the advanced age, the presence of comorbidities, and...
7.
Karakatsanis S, Panitsas F, Arapaki M, Galopoulos D, Asimakopoulos J, Liaskas A, et al.
Leuk Lymphoma
. 2022 Feb;
63(4):799-812.
PMID: 35188040
Serum ferritin (SF) is frequently elevated in classical Hodgkin lymphoma (cHL). We report on its prognostic significance in an unselected series of 529 cHL patients treated with state-of-the-art therapy. Higher...
8.
Chatzikonstantinou T, Kapetanakis A, Scarfo L, Karakatsoulis G, Allsup D, Cabrero A, et al.
Leukemia
. 2021 Nov;
35(12):3444-3454.
PMID: 34725454
Patients with chronic lymphocytic leukemia (CLL) may be more susceptible to Coronavirus disease 2019 (COVID-19) due to age, disease, and treatment-related immunosuppression. We aimed to assess risk factors of outcome...
9.
Papadakis V, Efstathopoulou M, Angelopoulou M, Tsourouflis G, Prassopoulos V, Rondogianni P, et al.
Leuk Lymphoma
. 2020 Nov;
62(3):722-726.
PMID: 33233976
No abstract available.
10.
Belia M, Chatzidimitriou C, Rondogianni P, Petsa P, Efstathopoulou M, Konstantinou E, et al.
Hematol Oncol
. 2020 Sep;
39(2):258-262.
PMID: 32905619
No abstract available.